Jiawen Pang
CIK: 0002113118
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UPC
Universe Pharmaceuticals INC
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Pang Jiawen
Pang Jiawen (SEC CIK 0002113118) files insider reports with the SEC as Director of Universe Pharmaceuticals INC (UPC).
Signal8 holds 1 ownership filing by Pang Jiawen, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Pang Jiawen's filings is in JI'AN, JIANGXI.
Other insiders filing for Universe Pharmaceuticals INC (UPC)
- Lai Gang, Chief Executive Officer
- Zheng Ding, Director
- Liu Baochang, Chief Operating Officer
- Yang Lin (Lydia), Chief Financial Officer
- Yu Yongping, Director